Humira Copycats for Psoriasis Backed by Real-World Outcomes

[ad_1]

(MedPage Today) — Two adalimumab biosimilars (Amjevita and Imraldi) worked as well for moderate to severe psoriasis as the original brand-name product (Humira) for patients either starting or switching treatment, according to real-world data from…

[ad_2]

Source link : https://www.medpagetoday.com/dermatology/psoriasis/114532

Author :

Publish date : 2025-03-06 22:45:00

Copyright for syndicated content belongs to the linked Source.